Xiansheng Leng

Title: Xiansheng Leng: Innovator in Phosphatidylinositol 3-Kinase Delta Inhibitors

Introduction

Xiansheng Leng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for human phosphatidylinositol 3-kinase delta (PI3K-delta). With a total of 2 patents, his work is crucial for advancing treatments for various diseases.

Latest Patents

Xiansheng Leng's latest patents focus on purine inhibitors of human phosphatidylinositol 3-kinase delta. The instant invention provides compounds of formula I, which are identified as PI3K-delta inhibitors. These compounds are particularly useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, chronic obstructive pulmonary disease (COPD), and cancer.

Career Highlights

Xiansheng Leng is associated with Merck Sharp & Dohme Corporation, where he continues to innovate and contribute to the pharmaceutical industry. His research and inventions are paving the way for new therapeutic options in treating complex diseases.

Collaborations

Xiansheng has collaborated with notable colleagues, including Abdelghani Achab and Michael D Altman. These partnerships enhance the research and development efforts in the field of PI3K-delta inhibitors.

Conclusion

Xiansheng Leng's work in developing PI3K-delta inhibitors represents a significant advancement in medical science. His contributions are vital for the ongoing fight against various diseases, showcasing the importance of innovation in healthcare.